Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CMPS is expected to report earnings to rise 31.80% to -39 cents per share on July 30
Q2'26
Est.
$-0.40
Q1'26
Beat
by $0.13
Q4'25
Missed
by $0.60
Q3'25
Missed
by $1.04
Q2'25
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -30 cents, beating the estimate of -43 cents. With 4.27M shares outstanding, the current market capitalization sits at 1.63B.